指南与共识新发突发、热带与寄生虫病

IDSA 2020年巴贝虫病诊断与管理临床实践指南

Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis.
指南 / 共识 · Clin Infect Dis · 2021-01-01

美国感染病学会(IDSA)发布2020年巴贝虫病诊断与管理指南,旨在为诊断和治疗巴贝虫病提供循证指导。巴贝虫病与莱姆病共感染的诊治由IDSA、美国神经病学学会(AAN)和美国风湿病学会(ACR)另行制定指南。人粒细胞无形体病的诊治建议见美国疾病控制与预防中心近期发布的立克次体病指南。

要点

  • 本指南针对巴贝虫病的诊断与管理提供循证推荐。
  • 巴贝虫病与莱姆病共感染的诊治不在本指南范围内。
  • 人粒细胞无形体病诊治参见CDC立克次体病指南。

核心结论

  • 本指南为巴贝虫病诊断与管理的最有效策略提供循证指导。

研究设计与样本

  • 美国感染病学会(IDSA)制定的临床实践指南,制定方法与样本量原文未报告。

临床怎么用

  • 目标读者包括接诊该病的内科医师与专科医师,如感染病、急诊、重症、血液及输血医学专家。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The purpose of this guideline is to provide evidence-based guidance for the most effective strategies for the diagnosis and management of babesiosis. The diagnosis and treatment of co-infection with babesiosis and Lyme disease will be addressed in a separate Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) guideline [1]. Recommendations for the diagnosis and treatment of human granulocytic anaplasmosis can be found in the recent rickettsial disease guideline developed by the Centers for Disease Control and Prevention [2]. The target audience for the babesiosis guideline includes primary care physicians and specialists caring for this condition, such as infectious diseases specialists, emergency physicians, intensivists, internists, pediatricians, hematologists, and transfusion medicine specialists.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Krause PJ, Auwaerter PG, Bannuru RR, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clin Infect Dis. 2021. PMID: 33252652. doi:10.1093/cid/ciaa1216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。